Document is current
Any future updates will be listed below
-
Authors
Rood, Jennifer E.
Wynne, Samantha
Robson, Lucia
Hupalowska, Anna
Randell, John
Teichmann, Sarah A. https://orcid.org/0000-0002-6294-6366
Regev, Aviv https://orcid.org/0000-0003-3293-3158
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 1 November 2024
First Online: 20 November 2024
Competing interests
: J.E.R., A.H. and A.R. are employees of Genentech, a member of the Roche Group and have equity in Roche. A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas and, until 31 July 2020, was an scientific advisory board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov. A.R. is a named inventor on multiple filed patents related to single-cell and spatial genomics. In the past three years, S.A.T. has consulted for or been a member of scientific advisory boards at Qiagen, Sanofi, GlaxoSmithKline and ForeSite Labs. S.A.T. is a consultant and equity holder for TransitionBio and EnsoCell. From 8 January 2024, S.A.T. is a part-time employee of GlaxoSmithKline.
